Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C404910 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the expression of CP mRNA | affects expression | 19414516
|
C404910 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of CP mRNA] | affects expression|affects reaction | 19414516
|
C404910 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of CP mRNA] | affects expression|affects reaction | 19414516
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CP mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of CP mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of CP mRNA | decreases expression | 18648102
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of CP mRNA | decreases expression | 18289764
|
C041594 |
4-nonylphenol |
4-nonylphenol affects the expression of CP mRNA | affects expression | 15792627
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CP mRNA | affects expression | 17562736
|
D000242 |
Cyclic AMP |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of CP mRNA] | affects expression|affects reaction | 19414516
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CP mRNA | affects expression | 16483693
|
D000968 |
Antimycin A |
Antimycin A results in decreased expression of CP mRNA | decreases expression | 19019832
|
D000968 |
Antimycin A |
Antimycin A results in decreased expression of CP protein | decreases expression | 19019832
|
D000968 |
Antimycin A |
Antimycin A results in increased degradation of CP mRNA | increases degradation | 19019832
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of CP mRNA | decreases expression | 20458559
|
D001414 |
Bacitracin |
Bacitracin results in increased expression of CP mRNA | increases expression | 18289764
|
C002478 |
bathocuproine |
bathocuproine inhibits the reaction [Pyruvaldehyde promotes the reaction [CP protein binds to CP protein]] | affects binding|decreases reaction|increases reaction | 16756764
|
C028559 |
bathocuproine sulfonate |
bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[JUN protein binds to FOS protein] which results in increased expression of and results in increased activity of CP protein]] | affects binding|decreases reaction|increases activity|increases expression|increases reaction | 17032174
|
C028559 |
bathocuproine sulfonate |
bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid results in increased expression of CP protein] | decreases reaction|increases expression | 17032174
|
C002791 |
bismuth tripotassium dicitrate |
bismuth tripotassium dicitrate results in decreased expression of CP mRNA | decreases expression | 15912405
|
D001761 |
Bleomycin |
Bleomycin results in increased expression of CP protein | increases expression | 12624602
|
D001761 |
Bleomycin |
tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CP protein] | decreases reaction|increases expression | 12624602
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of CP mRNA | decreases expression | 14729362
|
D002118 |
Calcium |
Calcium binds to CP protein | affects binding | 17242517
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of CP mRNA | increases expression | 18178546
|
D003300 |
Copper |
Copper binds to CP protein | affects binding | 17242517
|
D003300 |
Copper |
Copper promotes the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[JUN protein binds to FOS protein] which results in increased expression of and results in increased activity of CP protein]] | affects binding|increases activity|increases expression|increases reaction | 17032174
|
D003300 |
Copper |
Copper promotes the reaction [pyrrolidine dithiocarbamic acid results in increased expression of CP protein] | increases expression|increases reaction | 17032174
|
D003300 |
Copper |
Copper results in increased activity of CP protein | increases activity | 10949969
|
D003300 |
Copper |
CP protein binds to Copper | affects binding | 16842975
|
D003300 |
Copper |
[Copper co-treated with Diethylnitrosamine] results in increased expression of CP protein | affects cotreatment|increases expression | 20302851
|
D003345 |
Corticosterone |
Corticosterone results in increased expression of CP mRNA | increases expression | 15755911
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of CP mRNA | decreases expression | 20106945
|
D003907 |
Dexamethasone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA | affects cotreatment|decreases expression | 16054899
|
D003907 |
Dexamethasone |
[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
D003907 |
Dexamethasone |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
D002945 |
Cisplatin |
Cisplatin results in increased expression of CP mRNA | increases expression | 18289764
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of CP mRNA | decreases expression | 18042831
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of CP mRNA | increases expression | 18503570
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of and results in increased activity of CP protein | increases activity|increases expression | 19061943
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of CP mRNA | increases expression | 19061943
|
D004052 |
Diethylnitrosamine |
Iron inhibits the reaction [Diethylnitrosamine results in increased expression of CP protein] | decreases reaction|increases expression | 19061943
|
D004052 |
Diethylnitrosamine |
[Copper co-treated with Diethylnitrosamine] results in increased expression of CP protein | affects cotreatment|increases expression | 20302851
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of CP mRNA | decreases expression | 19638242
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of CP mRNA | increases expression | 15289156
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of CP mRNA | increases expression | 14996990
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of CP protein | increases expression | 14996990
|
D004050 |
Ditiocarb |
Ditiocarb inhibits the reaction [Pyruvaldehyde promotes the reaction [CP protein binds to CP protein]] | affects binding|decreases reaction|increases reaction | 16756764
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CP mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of CP mRNA | increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol affects the expression of CP mRNA | affects expression | 15598610
|
D004958 |
Estradiol |
Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of CP mRNA] | decreases reaction|increases expression | 16977382
|
D004958 |
Estradiol |
Estradiol results in increased expression of CP mRNA | increases expression | 15289156 16684588
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of CP mRNA | decreases expression | 16954407
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of CP protein | affects cotreatment|increases expression | 12616983
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CP mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CP mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of CP mRNA | decreases expression | 15576828 16940010
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in increased expression of CP protein | increases expression | 12616983
|
D005472 |
Fluorouracil |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CP mRNA] | affects reaction|decreases expression | 15016801
|
C030544 |
formic acid |
formic acid inhibits the reaction [Pyruvaldehyde promotes the reaction [CP protein binds to CP protein]] | affects binding|decreases reaction|increases reaction | 16756764
|
C056933 |
fumonisin B1 |
fumonisin B1 results in increased expression of CP mRNA | increases expression | 16221962
|
C039281 |
furan |
furan results in decreased expression of CP mRNA | decreases expression | 15120968
|
D019833 |
Genistein |
Genistein results in increased expression of CP mRNA | increases expression | 15289156
|
D005839 |
Gentamicins |
Gentamicins results in increased expression of CP mRNA | increases expression | 18289764
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of CP protein | affects cotreatment|increases expression | 12616983
|
C010176 |
halofuginone |
halofuginone results in increased expression of CP mRNA | increases expression | 17180598
|
D006581 |
Hexachlorobenzene |
Hexachlorobenzene results in increased expression of CP mRNA | increases expression | 15159207
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of and results in decreased secretion of CP protein | decreases expression|decreases secretion | 19019832
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of CP mRNA | decreases expression | 19019832
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased degradation of CP mRNA | increases degradation | 19019832
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of CP mRNA | decreases expression | 14729362
|
D007501 |
Iron |
[CP protein co-treated with TF protein] results in increased export of Iron | affects cotreatment|increases export | 16806171
|
D007501 |
Iron |
CP protein promotes the reaction [TF protein binds to Iron] | affects binding|increases reaction | 16806171
|
D007501 |
Iron |
CP protein results in increased export of Iron | increases export | 16806171
|
D007501 |
Iron |
CP gene mutant form results in increased abundance of Iron | increases abundance | 16988052
|
D007501 |
Iron |
[CP gene mutant form results in increased abundance of Iron] which results in decreased expression of TFRC mRNA | decreases expression|increases abundance | 16988052
|
D007501 |
Iron |
[CP gene mutant form results in increased abundance of Iron] which results in increased expression of FTH1 mRNA | increases abundance|increases expression | 16988052
|
D007501 |
Iron |
[CP gene mutant form results in increased abundance of Iron] which results in increased expression of FTL mRNA | increases abundance|increases expression | 16988052
|
D007501 |
Iron |
[CP gene mutant form results in increased abundance of Iron] which results in increased expression of SLC11A1 mRNA | increases abundance|increases expression | 16988052
|
D007501 |
Iron |
Iron inhibits the reaction [Diethylnitrosamine results in increased expression of CP protein] | decreases reaction|increases expression | 19061943
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA | affects cotreatment|decreases expression | 16054899
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
D015056 |
1-Methyl-3-isobutylxanthine |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
D008070 |
Lipopolysaccharides |
Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of CP mRNA] | decreases reaction|increases expression | 16977382
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of CP mRNA | increases expression | 16977382
|
C004925 |
methylmercuric chloride |
methylmercuric chloride results in increased expression of CP mRNA | increases expression | 17961207
|
D019810 |
Sodium Azide |
Sodium Azide inhibits the reaction [Pyruvaldehyde promotes the reaction [CP protein binds to CP protein]] | affects binding|decreases reaction|increases reaction | 16756764
|
D015058 |
1-Naphthylisothiocyanate |
1-Naphthylisothiocyanate results in increased expression of CP mRNA | increases expression | 15913567
|
D015058 |
1-Naphthylisothiocyanate |
1-Naphthylisothiocyanate results in increased expression of CP mRNA | increases expression | 18289764
|
D005996 |
Nitroglycerin |
Nitroglycerin results in decreased expression of CP mRNA | decreases expression | 12102619
|
C041786 |
palm oil |
palm oil results in decreased expression of CP mRNA | decreases expression | 18042831
|
C084656 |
paricalcitol |
[Phosphorus co-treated with paricalcitol] results in increased expression of CP mRNA | affects cotreatment|increases expression | 17715259
|
D010758 |
Phosphorus |
[Phosphorus co-treated with paricalcitol] results in increased expression of CP mRNA | affects cotreatment|increases expression | 17715259
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of CP mRNA | decreases expression | 16221962
|
D011374 |
Progesterone |
Progesterone affects the expression of CP mRNA | affects expression | 17251523
|
C020972 |
pyrrolidine dithiocarbamic acid |
bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[JUN protein binds to FOS protein] which results in increased expression of and results in increased activity of CP protein]] | affects binding|decreases reaction|increases activity|increases expression|increases reaction | 17032174
|
C020972 |
pyrrolidine dithiocarbamic acid |
bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid results in increased expression of CP protein] | decreases reaction|increases expression | 17032174
|
C020972 |
pyrrolidine dithiocarbamic acid |
Copper promotes the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[JUN protein binds to FOS protein] which results in increased expression of and results in increased activity of CP protein]] | affects binding|increases activity|increases expression|increases reaction | 17032174
|
C020972 |
pyrrolidine dithiocarbamic acid |
Copper promotes the reaction [pyrrolidine dithiocarbamic acid results in increased expression of CP protein] | increases expression|increases reaction | 17032174
|
C020972 |
pyrrolidine dithiocarbamic acid |
pyrrolidine dithiocarbamic acid results in increased expression of CP mRNA | increases expression | 17032174
|
C020972 |
pyrrolidine dithiocarbamic acid |
pyrrolidine dithiocarbamic acid results in increased expression of CP protein | increases expression | 17032174
|
C020972 |
pyrrolidine dithiocarbamic acid |
pyrrolidine dithiocarbamic acid results in increased secretion of CP protein | increases secretion | 17032174
|
D011765 |
Pyruvaldehyde |
bathocuproine inhibits the reaction [Pyruvaldehyde promotes the reaction [CP protein binds to CP protein]] | affects binding|decreases reaction|increases reaction | 16756764
|
D011765 |
Pyruvaldehyde |
Ditiocarb inhibits the reaction [Pyruvaldehyde promotes the reaction [CP protein binds to CP protein]] | affects binding|decreases reaction|increases reaction | 16756764
|
D011765 |
Pyruvaldehyde |
formic acid inhibits the reaction [Pyruvaldehyde promotes the reaction [CP protein binds to CP protein]] | affects binding|decreases reaction|increases reaction | 16756764
|
D011765 |
Pyruvaldehyde |
Pyruvaldehyde promotes the reaction [CP protein binds to CP protein] | affects binding|increases reaction | 16756764
|
D011765 |
Pyruvaldehyde |
Pyruvaldehyde results in decreased activity of CP protein | decreases activity | 16756764
|
D011765 |
Pyruvaldehyde |
Sodium Azide inhibits the reaction [Pyruvaldehyde promotes the reaction [CP protein binds to CP protein]] | affects binding|decreases reaction|increases reaction | 16756764
|
C089730 |
rosiglitazone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA | affects cotreatment|decreases expression | 16054899
|
C089730 |
rosiglitazone |
[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
C089730 |
rosiglitazone |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
D012402 |
Rotenone |
Rotenone results in decreased expression of CP mRNA | decreases expression | 19019832
|
D012402 |
Rotenone |
Rotenone results in decreased expression of CP protein | decreases expression | 19019832
|
D012402 |
Rotenone |
Rotenone results in increased degradation of CP mRNA | increases degradation | 19019832
|
D012964 |
Sodium |
Sodium binds to CP protein | affects binding | 17242517
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of CP mRNA | affects expression | 16507464
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CP mRNA | increases expression | 17884332
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CP mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CP mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with EGF protein] results in increased expression of CP mRNA | affects cotreatment|increases expression | 16054899
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CP mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CP mRNA] | affects cotreatment|decreases expression|decreases reaction | 16054899
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CP mRNA | decreases expression | 18796159 18172886
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CP mRNA | increases expression | 16054899
|
C020809 |
tetrathiomolybdate |
tetrathiomolybdate inhibits the reaction [Bleomycin results in increased expression of CP protein] | decreases reaction|increases expression | 12624602
|
D014527 |
Uric Acid |
Uric Acid affects the activity of CP protein | affects activity | 10949969
|
D014640 |
Vancomycin |
Vancomycin results in increased expression of CP mRNA | increases expression | 18289764
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
methylmercuric chloride |
6.66 | 6734493 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
6.66 | 14514962 15322242 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.92 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.29 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
7.23 | 12690470 15814532 17670903 |
MESH:D058186 |
Acute Kidney Injury |
|
Gentamicins |
7.23 | 11274264 |
MESH:D055371 |
Acute Lung Injury |
|
Bleomycin |
11.99 | 17118201 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
11.99 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
11.99 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
14.31 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
14.31 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
14.31 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
14.31 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
14.31 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
14.31 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
5.32 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
5.32 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
13.58 | 18056438 19052882 16434500 17620307 17162532 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
13.58 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
13.58 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.05 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.25 | 16712894 17306315 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
5.01 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Copper |
5.77 | 16410023 16325427 16866297 17119284 16962711 16886094 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
5.77 | 16640825 16563566 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
5.77 | 19621015 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.87 | 15469931 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Copper |
3.87 | 10694572 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
11.65 | 15504547 17963324 16511603 |
MESH:D000740 |
Anemia |
|
Iron |
11.65 | 16566752 16434484 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
11.65 | 11748828 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Copper |
8.60 | 16614410 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
8.60 | 17163184 17147795 17375513 17162259 16569441 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
4.23 | 16910769 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.19 | 10982225 |
MESH:D000860 |
Anoxia |
|
Bleomycin |
4.77 | 15782499 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
3.81 | 16604332 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
7.84 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
7.84 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
5.95 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
5.95 | 15885639 |
MESH:D015210 |
Arthritis, Gouty |
|
Uric Acid |
6.09 | 19655406 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
4.81 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
3.31 | 16640825 16632123 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 15363659 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.16 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.16 | 17352947 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
4.55 | 16640825 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.36 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
11.95 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
11.95 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
11.95 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.14 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.32 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
4.23 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.68 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.63 | 15665606 15845082 15380490 |
MESH:D001932 |
Brain Neoplasms |
|
Copper |
4.00 | 17079463 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
8.34 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
8.34 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Copper |
8.34 | 15986119 17079463 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
8.34 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
8.34 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
8.34 | 15324884 17129689 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
8.34 | 17289903 17018787 19861407 18497071 17261762 14630087 16675129 12948864 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
8.34 | 16110121 16595493 18357371 16557594 19217205 15136595 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
8.34 | 16873071 16541309 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Hexachlorobenzene |
8.34 | 15061365 12709520 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
8.34 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
8.34 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.73 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.82 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.01 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
6.47 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
6.47 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
25.48 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
25.48 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
25.48 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
25.48 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
25.48 | 15553829 16217749 11135700 14691202 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
25.48 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
25.48 | 19052882 19701751 18788625 17428255 18210153 20007298 16935385 19539802 3084413 17138121 20514400 20935162 20214788 19394651 16502159 16779866 17761372 20084675 16328049 17978847 16878318 16288022 20727157 19335982 18506893 19822196 16569478 3581430 18393292 21159647 18494052 20524982 16681979 18785209 19418558 17173139 19107877 19171122 18971187 11831363 19208518 16830150 20512989 19519916 10672840 16540662 19383236 16807293 20432363 16698587 20101231 18978308 19919837 17055752 17162532 10737359 18665156 18056438 18691550 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
25.48 | 15948411 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
25.48 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
25.48 | 17045692 16332177 18930000 17088986 17971768 16799960 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
25.48 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
25.48 | 15276417 16507464 17306315 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
2.78 | 12023789 16685392 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.22 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
5.35 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
5.35 | 18695887 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.55 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Bleomycin |
11.80 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
11.80 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
11.80 | 6189445 18337622 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
11.80 | 17066447 16757204 18986760 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
11.80 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Copper |
5.75 | 17327471 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
5.75 | 18670907 18850075 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
7.35 | 16640825 |
MESH:D009202 |
Cardiomyopathies |
|
tetrathiomolybdate |
7.35 | 16242529 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
3.20 | 16604332 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
5.98 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
5.98 | 16936243 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.17 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
20.36 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
20.36 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
20.36 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
20.36 | 17174075 7505956 21159647 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
20.36 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
20.36 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.50 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.50 | 16835633 |
MESH:D002761 |
Cholangitis |
|
1-Naphthylisothiocyanate |
5.55 | 12912871 |
MESH:D002779 |
Cholestasis |
|
1-Naphthylisothiocyanate |
20.09 | 18590720 15500046 7624871 12927374 16629650 18164287 15913567 19486331 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
20.09 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
20.09 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
20.09 | 16105132 17681005 16919318 17110522 15861022 17333356 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
20.09 | 19176532 |
MESH:D002780 |
Cholestasis, Intrahepatic |
|
1-Naphthylisothiocyanate |
5.20 | 10220858 19407337 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.80 | 16354765 8697196 12621046 15668235 15340226 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
6.96 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
6.96 | 17169374 16510598 16340194 17725105 17172411 15001691 17287894 17016597 18772588 17018589 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
6.96 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
6.96 | 16640825 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.04 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
3.04 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.04 | 17094418 15148649 17016601 16303861 18288408 18383874 17401013 20501625 14970324 17695437 17255274 17454858 16331619 18802399 15289873 18509181 17594712 16282729 18949393 16524972 18448328 16391804 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.51 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.57 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.27 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
3.27 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 15322242 20055451 10048152 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
3.95 | 12952375 16002989 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
8.82 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
8.82 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.15 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.50 | 15213294 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
5.03 | 14531868 11298694 18759878 8970840 2524372 11906362 12868966 8156756 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
5.03 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.09 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
2.90 | 3621924 2952479 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
7.86 | 16640825 16604332 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
7.86 | 17446233 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
marker/mechanism |
|
| 20012460 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
5.66 | 16506275 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Uric Acid |
5.66 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
11.39 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
11.39 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
11.39 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
11.39 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
11.39 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
2.87 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
3.87 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.11 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
1-Naphthylisothiocyanate |
21.03 | 17522070 18289764 20133375 7624871 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
21.03 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
21.03 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
21.03 | 18692083 7440962 6482804 1440618 9022650 16192314 11289319 18289764 9328219 8291058 9653073 18648102 6679447 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
21.03 | 16485898 19739265 10774834 12958197 12153990 12594235 11529661 16109766 12540782 11834606 15619225 19923254 11743745 14986274 11739529 11421492 12392966 11287661 16393943 2444490 19370779 16227642 14550746 16177239 17562736 19164858 14725611 16081117 11461765 17906064 19416960 19420014 18713872 15968718 16781746 17522070 10663392 19085960 12705907 10915739 18071297 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
21.03 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
21.03 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
21.03 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
21.03 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.44 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
11.03 | 15033597 12649298 19839026 12231392 |
MESH:D004362 |
Drug Toxicity |
|
Gentamicins |
11.03 | 11033412 15033597 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
11.03 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
2.97 | 18367378 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.85 | 12438553 |
MESH:D004487 |
Edema |
|
Bleomycin |
15.65 | 17118201 |
MESH:D004487 |
Edema |
|
Dexamethasone |
15.65 | 19703484 |
MESH:D004487 |
Edema |
|
pirinixic acid |
15.65 | 12083418 |
MESH:D004487 |
Edema |
|
rosiglitazone |
15.65 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
15.65 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.25 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
11.86 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
11.86 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
11.86 | 17692515 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
9.76 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
9.76 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
9.93 | 15700306 16804899 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
9.93 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
9.93 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
7.07 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.07 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
3.76 | 15328337 17637181 15821434 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.46 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.62 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
8.62 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
8.62 | 16481741 16785472 15173087 17638652 15464296 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
8.62 | 16481741 15173087 16785472 16337965 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.52 | 11564622 |
MESH:C536004 |
Familial apoceruloplasmin deficiency |
marker/mechanism |
|
| |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
33.26 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
33.26 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
33.26 | 18296743 19004024 17967931 19551842 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
33.26 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
33.26 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Iron |
33.26 | 16640825 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
33.26 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
33.26 | 19196556 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.23 | 16611131 16513791 16534752 16002989 15751030 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.83 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.46 | 9205823 11852909 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.36 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
11.12 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
11.12 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
11.12 | 20067830 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
4.80 | 16604332 16640825 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.65 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.02 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
10.68 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
10.68 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.58 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
2.82 | 16598420 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.58 | 16145905 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.44 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.94 | 10696789 |
MESH:D006261 |
Headache |
|
Nitroglycerin |
4.54 | 11554966 11284996 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
6.47 | 15102660 15464296 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
6.47 | 15162350 18337622 15102660 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
8.47 | 19898482 |
MESH:D034381 |
Hearing Loss |
|
Gentamicins |
8.47 | 19130971 18024279 15968427 17868369 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
3.88 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
1.96 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.12 | 20558911 |
MESH:D006432 |
Hemochromatosis |
marker/mechanism |
|
| 17258727 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
4.00 | 16604332 16574947 17255318 16640825 17053826 17236123 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.78 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.82 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.76 | 11000095 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
4.56 | 16604332 |
MESH:D006505 |
Hepatitis |
|
1-Naphthylisothiocyanate |
7.61 | 18590720 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
7.61 | 6705139 |
MESH:D006521 |
Hepatitis, Chronic |
|
Copper |
4.62 | 17338147 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
4.82 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Copper |
15.25 | 17182432 17276780 17109627 19888908 16607473 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
15.25 | 17182432 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
tetrathiomolybdate |
15.25 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
15.65 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
15.65 | 16890145 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
15.65 | 19772884 19176532 18467677 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
15.65 | 16120746 15340226 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.81 | 7520565 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.38 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.31 | 16597321 |
MESH:D006689 |
Hodgkin Disease |
|
Bleomycin |
9.34 | 17606976 15147373 18501091 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
9.34 | 16200630 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
9.34 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.10 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.39 | 15340226 16959395 8697196 18606429 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.17 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
6.17 | 12083418 |
MESH:D053565 |
Hypercalciuria |
|
Gentamicins |
5.06 | 17652376 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.02 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.62 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.03 | 21332399 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
14.87 | 15034207 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
14.87 | 14722030 12960047 |
MESH:D006965 |
Hyperplasia |
|
halofuginone |
14.87 | 11874485 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
6.88 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
6.88 | 17042910 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
6.88 | 18670907 18850075 |
MESH:D007006 |
Hypogonadism |
|
Iron |
3.93 | 16640825 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
9.16 | 16002989 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
9.16 | 16569931 16945680 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
4.46 | 16640825 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
4.79 | 18306037 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
3.78 | 15869954 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.75 | 15036965 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.87 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
5.14 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
5.14 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Bleomycin |
22.05 | 17118201 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
22.05 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
22.05 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
22.05 | 18785209 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
22.05 | 12878042 17963957 17255318 17237260 9205823 |
MESH:D007249 |
Inflammation |
|
Progesterone |
22.05 | 15869954 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
22.05 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
22.05 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
pyrrolidine dithiocarbamic acid |
4.91 | 18473937 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
14.00 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
14.00 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
14.00 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
14.00 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
marker/mechanism |
|
| 16988052 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
9.62 | 17163184 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
9.62 | 17255318 |
MESH:D007511 |
Ischemia |
marker/mechanism |
|
| 15668637 18091701 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.36 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.76 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
4.79 | 18306037 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.79 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
11.15 | 15464296 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Gentamicins |
11.15 | 18842672 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
26.85 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Bacitracin |
26.85 | 18289764 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
26.85 | 15190930 18289764 12231392 12649298 19839026 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
26.85 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
26.85 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Gentamicins |
26.85 | 18289764 19349640 17934191 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
26.85 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vancomycin |
26.85 | 18289764 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Copper |
8.48 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
8.48 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
26.98 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
26.98 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
26.98 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
26.98 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
26.98 | 16762066 15003126 14681315 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
26.98 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
26.98 | 16985049 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
16.06 | 16316344 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
16.06 | 11231351 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Gentamicins |
16.06 | 11231351 |
MESH:D007859 |
Learning Disorders |
|
Copper |
7.93 | 17134702 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
7.93 | 17184923 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Gentamicins |
3.94 | 10219319 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
5.23 | 15070760 |
MESH:D007938 |
Leukemia |
|
Genistein |
5.23 | 18980019 17468513 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.22 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.67 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
2.94 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.19 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.01 | 17050201 19850784 16968895 20471514 16467208 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
2.77 | 15336539 12712474 15748426 9834237 16331271 15213294 19225113 16112521 16966277 17712046 16330433 11468182 17869043 17649720 11161223 19035177 12679006 17217047 19075265 16891316 15622746 16823087 17107899 19642359 12018890 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.74 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.06 | 15821434 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
4.80 | 16563566 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
12.63 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
12.63 | 19638242 18665156 20032147 18407596 18522880 |
MESH:D008103 |
Liver Cirrhosis |
|
halofuginone |
12.63 | 17180598 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
12.63 | 16640825 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.77 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
13.34 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
13.34 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
13.34 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
halofuginone |
13.34 | 16489207 11172339 14739098 12175628 18458672 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
13.34 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
13.34 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pyrrolidine dithiocarbamic acid |
13.34 | 15078482 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
13.34 | 17347453 15980055 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
13.34 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
1-Naphthylisothiocyanate |
5.36 | 17184895 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
5.36 | 12969438 16610002 19784758 11587558 16611625 19460945 19014921 12587719 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
5.36 | 17034775 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
4.38 | 16737972 17207112 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.67 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
27.91 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
27.91 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Copper |
27.91 | 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
27.91 | 20137499 20452335 19073162 18754104 20492335 18977376 19255062 18644402 19256749 19426721 20583210 21278145 20405173 19294768 19638242 19812893 21047994 20501860 19833225 20118626 12112319 20101389 19427195 15175105 19690152 19551842 21071580 18978307 9163691 15885732 21167192 2422723 10737359 18648771 12771043 20434301 19996281 19254457 16942905 19090486 19499222 19850985 19642983 2862719 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
27.91 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
27.91 | 17045692 15113037 16603448 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
27.91 | 20302851 16640825 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
27.91 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
27.91 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
27.91 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
17.81 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
17.81 | 598648 3712494 1399818 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
17.81 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
17.81 | 18093689 18079962 17942915 18775883 16842330 16267830 18164116 18544905 3124819 19539802 9362446 19009564 18253720 17854601 19519916 2563599 18282651 21159647 18308698 19004024 19126423 17174075 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Hexachlorobenzene |
17.81 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
17.81 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.85 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.72 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
7.60 | 21114838 |
MESH:D055370 |
Lung Injury |
|
pyrrolidine dithiocarbamic acid |
7.60 | 16129981 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
13.08 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Bleomycin |
13.08 | 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
13.08 | 11798837 17225452 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
13.08 | 11195469 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
13.08 | 20970405 21163286 20512841 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
13.08 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
13.08 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
13.08 | 19931552 16712894 17077188 15276417 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
13.08 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.15 | 15086387 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.51 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
3.00 | 15700306 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.59 | 16640825 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.86 | 16002989 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
14.20 | 12807724 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
14.20 | 17203775 11807958 16891317 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
14.20 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
14.20 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
14.20 | 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.83 | 19453300 |
MESH:D008545 |
Melanoma |
|
Bleomycin |
4.45 | 15577320 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
4.45 | 15577323 18332650 16809738 12883367 16248763 18176117 17761969 11135225 17023156 12393984 16432458 18505091 12374674 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.45 | 19082730 16487513 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.13 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
2.94 | 19513568 |
MESH:D007706 |
Menkes Kinky Hair Syndrome |
|
Copper |
5.24 | 17109627 17268249 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
2.95 | 17638057 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
3.84 | 17261469 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.13 | 16801185 |
MESH:D008708 |
Methemoglobinemia |
|
Nitroglycerin |
4.15 | 3537620 |
MESH:D020326 |
Migraine without Aura |
|
Cyclic AMP |
9.15 | 11304026 |
MESH:D020326 |
Migraine without Aura |
|
Nitroglycerin |
9.15 | 14659530 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.13 | 18986760 16757204 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
5.86 | 19417148 14977855 19549372 15949261 11468182 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
5.86 | 15867202 16118317 15744524 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
5.02 | 17086897 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.88 | 16239165 |
MESH:D009137 |
Muscular Dystrophy, Animal |
|
Gentamicins |
5.62 | 18694830 |
MESH:D009181 |
Mycoses |
|
Iron |
4.82 | 16640825 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.02 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
6.22 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
6.22 | 9809623 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
7.76 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
Nitroglycerin |
7.76 | 14729435 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
7.76 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
7.44 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.44 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
16.18 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
16.18 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
16.18 | 16604332 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
16.18 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
8.22 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
8.22 | 7678174 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.35 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
4.69 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
4.69 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
11.91 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
11.91 | 15313581 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
11.91 | 16928823 18600527 18239605 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.91 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
11.91 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.05 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Copper |
8.23 | 17308104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
8.23 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
3.84 | 15464296 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.79 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
7.67 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
7.67 | 17178036 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.38 | 18619942 15790535 17356569 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
18.47 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
18.47 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
18.47 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
18.47 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
9.55 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
9.55 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
9.55 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.08 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
11.04 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
11.04 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
11.04 | 17296847 16604332 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.06 | 8761367 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.46 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
2.98 | 16436463 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
3.74 | 21332399 20518802 11836018 18674790 17217161 19632207 20132043 18457598 16723640 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
3.74 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
11.82 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
11.82 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
11.82 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.36 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
3.55 | 16640825 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
9.59 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
9.59 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Iron |
9.59 | 16640825 16648989 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.49 | 16169203 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
15.55 | 16624393 19769630 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
15.55 | 15464296 19769630 6897625 17225452 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
15.55 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
15.55 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
15.55 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
15.55 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Acetaminophen |
1.89 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
10.03 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
10.03 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
10.03 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
10.03 | 15113037 16929163 16500647 19003803 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.09 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
12.05 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
12.05 | 12065085 |
MESH:D010212 |
Papilloma |
|
Iron |
12.05 | 12065085 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.57 | 19927285 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.36 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Ditiocarb |
7.35 | 11445065 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
7.35 | 16563566 16640825 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
7.35 | 11445065 18619942 11535288 16140633 19114014 19232380 15451049 18191903 16412576 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.52 | 15795934 15574749 15927086 18197244 |
MESH:D016871 |
Pasteurellaceae Infections |
marker/mechanism |
|
| 16755360 |
MESH:D010382 |
Peliosis Hepatis |
|
1-Naphthylisothiocyanate |
11.62 | 20133375 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
11.62 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.70 | 15464296 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.82 | 6228378 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
11.89 | 14722030 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
11.89 | 16604332 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.04 | 16977796 15687265 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
4.69 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Bleomycin |
9.35 | 18024389 17071938 16317386 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
9.35 | 11605937 12224865 |
MESH:D011041 |
Poisoning |
|
Iron |
3.71 | 16604332 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
ethinyl estradiol-desogestrel combination |
5.03 | 17105841 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Hexachlorobenzene |
15.27 | 9918132 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
15.27 | 16640825 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
15.27 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
7.13 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
7.13 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.15 | 21297632 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
3.92 | 16640825 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
7.45 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
7.45 | 11896295 11118676 11222880 11399792 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.14 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.31 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.62 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.62 | 18247401 16289102 16644109 12479363 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
Copper |
2.62 | 17079463 17308104 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
2.62 | 15846301 17136230 15046698 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.62 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.62 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.62 | 15378649 15256057 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
pyrrolidine dithiocarbamic acid |
2.62 | 16139439 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.62 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Gentamicins |
4.13 | 15033597 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.36 | 16640825 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.68 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.97 | 16882103 |
MESH:D011654 |
Pulmonary Edema |
|
Bleomycin |
4.67 | 15808516 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Bleomycin |
5.91 | 12574379 21435439 15541506 17434272 11554783 15322207 16314464 18162602 14609568 17177178 12624602 17241526 18008008 16115399 |
MESH:D011658 |
Pulmonary Fibrosis |
|
tetrathiomolybdate |
5.91 | 12624602 15541506 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.46 | 15538739 18286688 18722050 16160472 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
8.59 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Gentamicins |
8.59 | 15728788 17132701 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.04 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
7.70 | 18379247 11700416 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
pyrrolidine dithiocarbamic acid |
7.70 | 16129981 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.28 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.23 | 18990726 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
4.05 | 16930377 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
2.88 | 3692021 |
MESH:D012173 |
Retinitis |
|
Gentamicins |
5.62 | 18644591 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.59 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
8.32 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
8.32 | 14601052 |
MESH:D012559 |
Schizophrenia |
marker/mechanism |
|
| 16842975 |
MESH:D012559 |
Schizophrenia |
|
Copper |
2.98 | 16842975 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
4.37 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
4.37 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
halofuginone |
3.31 | 11874485 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
14.26 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
14.26 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
14.26 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
14.26 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
14.26 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.69 | 15464296 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
9.54 | 16002989 16709447 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
9.54 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.64 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.29 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.68 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
4.01 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
4.01 | 18396642 17522103 15958060 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.01 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
4.01 | 19015929 17522103 16424979 18567086 17172411 18396642 19084572 17498489 15786421 16951190 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
2.94 | 15138204 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
4.81 | 16640825 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.04 | 15464296 17225452 |
MESH:D013921 |
Thrombocytopenia |
|
1-Naphthylisothiocyanate |
8.18 | 20133375 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
8.18 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
15.04 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
ethinyl estradiol-desogestrel combination |
15.04 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Gestodene |
15.04 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
7.73 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Gestodene |
7.73 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.25 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
9.06 | 3712494 1399818 6587162 7505956 6582329 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
9.06 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
9.06 | 7505956 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.03 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.43 | 16280240 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.32 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Iron |
3.66 | 16597321 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
19.51 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
19.51 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
19.51 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
19.51 | 12845720 20435036 12973940 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
19.51 | 15464296 17225452 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
19.51 | 16452187 16712894 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
19.51 | 16712894 16452187 17306315 11723127 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
9.86 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
9.86 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.39 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
18.06 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
18.06 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
18.06 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
18.06 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.52 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
7.45 | 15809267 16690809 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
7.45 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
9.60 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
9.60 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
9.00 | 15577323 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
9.00 | 16513791 16002989 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.78 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.94 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
8.91 | 15869587 14671159 |
MESH:D020246 |
Venous Thrombosis |
|
ethinyl estradiol-desogestrel combination |
8.91 | 15869587 |
MESH:D015837 |
Vestibular Diseases |
|
Gentamicins |
4.91 | 18776599 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.07 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.59 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.19 | 16723640 |
MESH:D015431 |
Weight Loss |
|
Bleomycin |
10.83 | 12624602 |
MESH:D015431 |
Weight Loss |
|
tetrathiomolybdate |
10.83 | 12624602 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.79 | 17120751 |